HEALTHCoronavirus Updates: What's the Latest? A Timeline of Recent EventsBy Steve Fiorillo11 hours ago
HEALTHCoronavirus Updates: What's the Latest? A Timeline of Recent EventsBy Steve Fiorillo11 hours ago
JIM CRAMERRough Road Ahead: Cramer's 'Mad Money' Recap (Friday 2/28/20)By Scott RuttFeb 28, 2020 8:53 PM EST
MARKETSMarket Meltdown: How I’m Trading It and What the Fed, Treasury and SEC Should Do NowBy Stephen GuilfoyleFeb 28, 2020 11:55 AM EST
INVESTINGInovio Among Pharma Firms Prepping to Hit Go on Coronavirus VaccineBy M. Corey GoldmanFeb 28, 2020 10:32 AM EST
JIM CRAMERStay-at-Home Stocks: Cramer's 'Mad Money' Recap (Thursday 2/27/20)By Scott RuttFeb 27, 2020 8:44 PM EST
INVESTINGGilead Shares Gain After Launching Phase 3 Studies For Coronavirus TreatmentBy Martin BaccardaxFeb 27, 2020 9:39 AM EST
PRESS RELEASESModerna To Host Manufacturing & Digital Day On March 4, 2020By Business WireFeb 26, 2020 4:30 PM EST
INVESTINGModerna Surges on Heels of Solid Quarterly Report, Potential Coronavirus VaccineBy Scott Van VoorhisFeb 26, 2020 9:52 AM EST
MARKETSDow's Slump, Coronavirus Warnings, Bob Iger, Salesforce, Tesla - 5 Things You Must Know WednesdayBy Joseph WoelfelFeb 26, 2020 6:54 AM EST
JIM CRAMERCoronavirus and Your Portfolio: Cramer's 'Mad Money' Recap (Tuesday 2/25/20)By Scott RuttFeb 25, 2020 8:31 PM EST
MARKETSStocks Crumble Amid Warnings About Spread of CoronavirusBy Joseph WoelfelFeb 25, 2020 2:34 PM EST
MARKETSModerna, Coronavirus, Home Depot, Amazon, Expedia - 5 Things You Must Know TuesdayBy Joseph WoelfelFeb 25, 2020 7:17 AM EST
INVESTINGModerna Surges After Shipping Coronavirus Vaccine for Human TrialsBy Martin BaccardaxFeb 25, 2020 9:34 AM EST
PRESS RELEASESModerna Ships MRNA Vaccine Against Novel Coronavirus (mRNA-1273) For Phase 1 StudyBy Business WireFeb 24, 2020 6:04 PM EST
PRESS RELEASESModerna To Present At Upcoming Investor ConferencesBy Business WireFeb 24, 2020 8:00 AM EST
PRESS RELEASESModerna To Report Fourth Quarter And Full Year 2019 Financial Results On Wednesday, February 26th, 2020By Business WireFeb 12, 2020 4:30 PM EST
PRESS RELEASESModerna Announces Pricing Of Public Offering Of Shares Of Common StockBy Business WireFeb 11, 2020 10:12 PM EST
PRESS RELEASESModerna Announces Progress In Prophylactic Vaccines Modality With CMV Vaccine Phase 2 Study Data Now Expected In Third Quarter 2020 And Expands Investment In This Core Modality With Three New Development CandidatesBy Business WireFeb 10, 2020 5:11 PM EST
PRESS RELEASESModerna Announces First Patient Enrolled In Phase 1/2 Study Of MRNA-3704 For Methylmalonic AcidemiaBy Business WireFeb 10, 2020 5:10 PM EST
PRESS RELEASESModerna Announces Proposed Public Offering Of Shares Of Common StockBy Business WireFeb 10, 2020 4:13 PM EST
